FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

23379 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some
Members targetComponentId
Adverse health risk due to mold in residence Mold growth in home (finding)
Adverse health risk due to radon in residence Radon in residence (finding)
bivirkning af surgørende midler All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
bivirkning af alkaliske midler All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
bivirkning af carbromalderivater Adverse reaction to carbromal
bivirkning af lægemidler med primær virkning på glatte muskler og skeletmuskler og respirationssystemet All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
bivirkning ved intravenøs diphosphonat Adverse reaction caused by bisphosphonate (disorder)
bivirkning af leverpræparater og andre antianæmiske midler All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
bivirkninger af stof Adverse reaction (disorder)
Adverse reaction to CNS depressants and anesthetics All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to agent affecting blood constituents NOS All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to agent affecting blood constituents NOS All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to agents primarily affecting blood constituents All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to agents primarily affecting blood constituents All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to anti-infective NOS Anti-infectives adverse reaction (disorder)
Adverse reaction to anti-infective NOS Anti-infectives adverse reaction (disorder)
Adverse reaction to antiasthmatic NOS All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to anticonvulsant and antiparkinsonism drugs NOS All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to anticonvulsants and anti-parkinsonism drugs All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to antiparkinsonism drug All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to antiparkinsonism drugs NOS All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to bromine compound Adverse reaction caused by bromine and/or bromine compound (disorder)
Adverse reaction to cardiac glycoside Adverse reaction to Digitalis glycoside
Adverse reaction to cardiac glycosides NOS Adverse reaction to Digitalis glycoside
Adverse reaction to central nervous system depressant All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to central nervous system muscle-tone depressants NOS All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to clomocycline sodium Adverse reaction to clomocycline
Adverse reaction to clorazepate dipotassium Adverse reaction to clorazepate
Adverse reaction to component of vaccine product containing Severe acute respiratory syndrome coronavirus 2 antigen or Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid Adverse reaction to COVID-19 vaccine
Adverse reaction to dental drugs topically applied All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to drug NOS All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to drug NOS All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to drug primarily affecting the autonomic nervous system NOS All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to drug primarily affecting the cardiovascular system NOS All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to drug primarily affecting the cardiovascular system NOS All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to drugs primarily affecting autonomic nervous system All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to drugs primarily affecting gastrointestinal system All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to drugs primarily affecting gastrointestinal system All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to drugs primarily affecting skin and mucous membrane, ophthalmological, otorhinolaryngological and dental drugs All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to drugs primarily affecting the cardiovascular system All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to drugs primarily affecting the cardiovascular system All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to drugs primarily affecting the gastrointestinal system NOS All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to liver preparations and other antianemic agents NOS All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to other agent affecting blood constituents All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to other agent affecting blood constituents NOS All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to other bacterial vaccine NOS Adverse reaction to bacterial vaccine
Adverse reaction to other central nervous system depressants and anesthetics All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to other drugs and medicines All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to other drugs and medicines All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to other drugs primarily affecting the gastrointestinal system All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to other muscle drugs All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to other opiates and related narcotics Opioid analgesic adverse reaction
Adverse reaction to other opiates and related narcotics Opioid analgesic adverse reaction
Adverse reaction to other psychotropic agent All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to other respiratory system drugs All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to other skin, mucous membrane, ophthalmological, otorhinolaryngological and dental drugs All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to psychotropic agent All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to psychotropic agent NOS All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to skin, mucous membrane, ophthalmological, otorhinolaryngological and dental drugs NOS All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Adverse reaction to sodium cromoglycate Adverse reaction to cromoglicic acid
Adverse reaction to sodium fusidate Fusidic acid adverse reaction
Advertising/public relations NOS Advertising/public relations
Advertising/public relations NOS Advertising/public relations
anafylaksi fremkaldt af luftbåret allergen Anaphylaxis
Infektion i gastrointestinalkanalen forårsaget af Aerobacter aerogenes Gastrointestinal infection caused by Klebsiella aerogenes
meningit forårsaget af Enterobacter Meningitis caused by Klebsiella aerogenes
Aeromonas aquariorum Aeromonas dhakensis
Aeromonas enteropelogenes Aeromonas trota
Aeromonas tructi Aeromonas trota
Aeronautical engineer NOS Aeronautical engineer
Aeronautical engineer NOS Aeronautical engineer
Aerosol or vapor inhalation for bronchodilation Inhaled bronchodilator therapy
Aerotherapy NOS Aerotherapy
Aerotherapy NOS Aerotherapy
Affect finding Mood finding
affektivt anfald An epileptic seizure originating within networks limited to one hemisphere presenting with an emotion or the appearance of having an emotion as an early prominent feature, regardless of whether aware or with impaired awareness. Some of these phenomena are subjective and must be recalled and reported by the individual. Emotions involve fear, anxiety, agitation, anger, paranoia, pleasure, joy, ecstasy and other emotions. The seizure also encompasses affective manifestations with the appearance of emotions occurring without subjective emotionality, such as gelastic (laughing) or dacrystic (crying).
Afipia felis Afipia felis
African trypanosomiasis antibody Trypanosoma brucei antibody
Agammaglobulinemia Congenital agammaglobulinemia
Aged parents Has elderly mother and father (finding)
Aggression caused by ingestible alcohol Aggression caused by ethanol (finding)
aggressivt digitalt papillært adenom Digital papillary adenocarcinoma
Agriculture machine op. NOS Agriculture machine operator
Agriculture machine operator NOS Agriculture machine operator
Agrobacterium radiobacter Rhizobium radiobacter (organism)
Agrobacterium tumefaciens Rhizobium radiobacter (organism)
Ahmed-tubeshunt Valved ophthalmic drainage device (physical object)
hjælpemidler til svært handicappede Provision of aid for severe disability
Aids for severely handicapped Provision of aid for severe disability
Air Air
Luftkontrastorbitografi Plain X-ray of orbit with contrast (procedure)
Air myelogram Myelogram
muskelpneumografi Myelogram
Air pressure effects NOS Effects of air pressure
Air pressure effects NOS Effects of air pressure
Air traffic planning/control NOS Air traffic planning/control
Air traffic planning/control NOS Air traffic planning/control
Albright hereditary osteodystrophy A heterogeneous group of endocrine disorders with characteristics of normal renal function and resistance to the action of parathyroid hormone (PTH), manifesting with hypocalcaemia, hyperphosphataemia and elevated PTH levels and that includes the subtypes PHP type 1a (PHP-1a) , PHP type 1b (PHP-1b), PHP type 1c (PHP-1c), PHP type 2 (PHP-2) and pseudopseudohypoparathyroidism (PPHP). PHP-1a, PPHP, and PHP-1b are all due to molecular defects in the same locus of the GNAS (20q13.2-q13.3) gene coding the alpha sub-unit of the stimulatory G protein. PHP can be sporadic or inherited autosomal dominantly with parental imprinting.
Albumin human + epoetin alfa 2.5mg/20000unt injection Epoetin alfa 20000 unit/mL solution for injection
humant albumin 2,5 mg + epoetin alfa 20.000 IE injektionsvæske, opløsning, hætteglas Epoetin alfa 20000 unit/mL solution for injection
albuterol 0,0417 % inhalationsvæske, opløsning Salbutamol sulfate 417 microgram/mL solution for inhalation

Start Previous Page 7 of 234 Next End

Reference Sets

Reference set descriptor

Back to Start